30-Oct-2026 12:56:39
AJANTPHARMGeneral news
AJANTA PHARMA Q2 FY27 ; NET PROFIT UP 49% AT ₹388 CR (YOY), UP 16% (QOQ)
REVENUE UP 33% AT ₹1,794 CR (YOY), UP 10% (QOQ) EBITDA UP 67% AT ₹548 CR (YOY), UP 29% (QOQ) MARGINS AT 30.50% VS 24.20% (YOY), 26.10% (QOQ)
AJANTA PHARMA LIMITED